Kindly MD Stock Plummets 55% After 590M Share Shelf Filing

Introduction

Kindly MD Inc (ticker: NAKA) is a healthcare company that integrates traditional primary care, pain management, behavioral health, and alternative therapies. Founded in 2019, Kindly MD offers in-person and telemedicine services across four clinics in Utah, focusing on mental-physical health integration, medical cannabis evaluations, weight-loss support, and recovery.

Ticker	Exchange	Price (USD)	Change (%)	Volume (shares)
NAKA	NASDAQ	1.23	–55.76	13,562,714

As of September 15, 2025, the stock traded at $1.23, representing a decrease of 55.76% from its prior close.

Corporate Structure

Kindly MD employs between 51 and 200 people, including board-certified family nurse practitioners, licensed behavioral health clinicians, and administrative staff. The leadership team is headed by CEO David Bailey, with founder Tim Pickett serving in an advisory role. The company’s organizational model integrates clinical services with digital operations to enhance patient access, supported by a team with experience in emergency medicine, trauma care, and evidence-based treatments.

Healthcare Integration by Greg Rosenke

Recent Developments and News

• May 2025: Announced a merger agreement with Nakamoto Holdings to form a publicly traded Bitcoin treasury vehicle alongside healthcare operations.
• August 14, 2025: Closed a PIPE (private investment in public equity) offering as part of its capital raising efforts.
• August 15, 2025: Issued convertible notes that allow for the conversion into up to 100 million shares.
• September 10, 2025: Filed Form 8-K to report material events and corporate disclosures.
• September 12, 2025: Filed Form S-8 to register securities under the 2022 and 2025 Equity Incentive Plans for employee benefits.
• September 15, 2025: Filed Form S-3ASR registering up to 590,259,274 shares of common stock, including shares underlying pre-funded warrants and convertible notes.

Financial and Strategic Analysis

Kindly MD’s financial position indicates strategic capital-raising initiatives and developing revenue streams:

• Market capitalization is approximately $462.7 million with 376.15 million shares outstanding.
• Trailing twelve-month revenue totaled $2.24 million; gross margin was 98.72%, while net margin was –244.09%.
• EPS (TTM): –0.86; P/E (TTM): –1.42; EBITDA (TTM): $5.39 million; ROE (TTM): 81.92%.
• The S-3ASR filing on September 15, 2025, allows for ongoing share sales, enabling the company to respond to market conditions while presenting potential dilution risks for existing shareholders.
• The S-8 registration supports employee retention strategies through equity incentives, aligning staff interests with longer-term performance.

Market Position and Industry Context

Kindly MD operates within a fragmented healthcare market where integrated care models and telemedicine are increasingly relevant. Its offerings in medical cannabis evaluation and weight-loss programs with GLP-1 medications distinguish it from conventional primary care practices. The merger with Nakamoto Holdings introduces a Bitcoin treasury management component, which may appeal to investors interested in healthcare innovation and digital assets. Kindly MD has been noted as a significant provider for plant-based treatment education in Utah, with partnerships covering a range of insurance plans.

tl;dr

On September 15, 2025, KINDLY MD INC (NAKA) shares decreased by 55.76% to $1.23 amid substantial trading volume. On the same day, the company filed a Form S-3ASR to register up to 590 million additional shares, part of ongoing PIPE and convertible note financings completed in August 2025. The merger with Nakamoto Holdings in May 2025 and newly registered equity under Form S-8 indicate continued capital-raising flexibility and employee incentive alignment. Future developments will depend on the execution of shelf offerings and the integration of healthcare services with the Bitcoin treasury vehicle.